Elevance Health, Inc. (ELV) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 125 transactions totaling $55.0M, demonstrating a bearish sentiment with -$49.3M in net insider flow. The most recent transaction on Oct 2, 2025 involved a transaction of 2,895 shares valued at $985.0K.
No significant insider buying has been recorded for ELV in the recent period.
No significant insider selling has been recorded for ELV in the recent period.
Based on recent SEC filings, insider sentiment for ELV is bearish with an Insider Alignment Score of 5/100 and a net flow of -$49.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Elevance Health, Inc. (ELV) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading ELV stock, having executed 125 transactions in the past 90 days. The most active insider is Gail Boudreaux (Executive), who has made 17 transactions totaling $38.5M.
Get notified when executives and directors at ELV file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | Kaye Mark | Executive | Payment | 2,895 | $340.24 | $985.0K | Large |
| Sep 3, 2025 | M. Wessling Erin | Executive | Payment | 152 | $321.59 | $48.9K | |
| Aug 19, 2025 | D. Devore Susan | Executive | Purchase | 1,200 | $312.15 | $374.6K | |
| Aug 1, 2025 | H. Collis Steven | Executive | Award | 639 | $N/A | $0 | |
| Jul 18, 2025 | Boudreaux Gail | Executive | Purchase | 1,050 | $287.96 | $302.4K | |
| Jul 18, 2025 | Boudreaux Gail | Executive | Purchase | 5,116 | $287.12 | $1.5M | Large |
| Jul 18, 2025 | Boudreaux Gail | Executive | Purchase | 2,334 | $286.07 | $667.7K | Large |
| Aug 5, 2024 | G. Peru Ramiro | Executive | Sale | 753 | $531.52 | $400.2K | 10b5-1 |
| Jul 22, 2024 | Boudreaux Gail | Executive | Sale | 20,779 | $500.36 | $10.4M | Large10b5-1 |
| Jul 22, 2024 | Boudreaux Gail | Executive | Sale | 1,100 | $498.50 | $548.4K | Large10b5-1 |
| Jul 22, 2024 | Boudreaux Gail | Executive | Sale | 2,250 | $504.27 | $1.1M | Large10b5-1 |
| Jul 22, 2024 | Boudreaux Gail | Executive | Sale | 6,621 | $501.40 | $3.3M | Large10b5-1 |
| Jul 22, 2024 | Boudreaux Gail | Executive | Sale | 2,250 | $502.23 | $1.1M | Large10b5-1 |
| Jul 22, 2024 | Boudreaux Gail | Executive | Sale | 1,000 | $503.67 | $503.7K | Large10b5-1 |
| Jul 19, 2024 | L. Dixon Robert Jr | Executive | Sale | 305 | $506.76 | $154.6K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 29 | $52.1M | 51.4% |
Payment(F) | 31 | $40.5M | 39.9% |
Exercise(M) | 4 | $6.0M | 5.9% |
Purchase(P) | 4 | $2.8M | 2.8% |
Award(A) | 56 | $0 | 0.0% |
Gift(G) | 1 | $0 | 0.0% |
Insider selling pressure at Elevance Health, Inc. has increased, with 22 insiders executing 125 transactions across all time. Total sales of $52.1M significantly outpace purchases of $2.8M, resulting in a net outflow of $49.3M. This selling activity appears largely discretionary, which may warrant closer attention from investors.